Connecting you to content on EBSCOhost

Works by Liao, Kai-Hsin

Results: 6

1

A Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 7, p. 855, doi. 10.1002/jcph.867

By:

Udata, Chandrasekhar;
Garzone, Pamela D.;
Gumbiner, Barry;
Joh, Tenshang;
Liang, Hong;
Liao, Kai‐Hsin;
Williams, Jason H.;
Meng, Xu

Publication type:

Article

2

Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1288, doi. 10.1111/cts.12829

By:

Liao, Kai‐Hsin;
Ko, Bor‐Sheng;
Chen, Liang‐Kung;
Hsiao, Fei‐Yuan

Publication type:

Article

3

Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 916, doi. 10.1111/cts.12778

By:

Shih, Yi‐Ru;
Liao, Kai‐Hsin;
Chen, Yen‐Hui;
Lin, Fang‐Ju;
Hsiao, Fei‐Yuan

Publication type:

Article

4

Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 6, p. 1568, doi. 10.1111/bcp.13094

By:

Williams, Jason H.;
Hutmacher, Matthew M.;
Zierhut, Matthew L.;
Becker, Jean ‐ Claude;
Gumbiner, Barry;
Spencer ‐ Green, George;
Melia, Lisa A.;
Liao, Kai ‐ Hsin;
Suster, Matthew;
Yin, Donghua;
Li, Ruifeng;
Meng, Xu

Publication type:

Article

5

Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based Therapeutic.

Published in:

AAPS Journal, 2020, v. 22, n. 4, p. 1, doi. 10.1208/s12248-020-00462-z

By:

Wang, Ying;
Smith, Judith F.;
Araya, Marcela M.;
Liao, Kai-Hsin (Ken);
Gorovits, Boris

Publication type:

Article

6

A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors.

Published in:

Investigational New Drugs, 2020, v. 38, n. 1, p. 120, doi. 10.1007/s10637-019-00754-y

By:

Rosen, Lee S.;
Wesolowski, Robert;
Baffa, Raffaele;
Liao, Kai-Hsin;
Hua, Steven Y.;
Gibson, Brenda L.;
Pirie-Shepherd, Steven;
Tolcher, Anthony W.

Publication type:

Article